Physician

Geoffrey Louis Tyson, M.D.

According to 2025 Medicare claims, Geoffrey Tyson, M.D. (NPI: 1679610778) practices anesthesiology in the Everett, WA market, with the plurality of this provider's patient population coming from Snohomish, WA. This provider's primary affiliated billing organization is SOUND PAIN ALLIANCE (NPI: 1649776394; TIN: 823663428) and primary practice location at 98043-2187. Tyson is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Tyson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 129 traditional Medicare patients, billed 2,159 HCPCS/CPT codes, and received $109,959 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 663 prescription claims across 149 beneficiaries totaling $39,299 in drug costs, led by Buprenorphine (Buprenorphine). DME data shows 12 claims. Open Payments data shows 75 records totaling $5,981. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $48,132 to $109,959. In contrast, Part D prescription costs have declined steadily, from $68,555 to $39,299. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	74	1,315	$48,132
2016	88	1,519	$50,963
2017	103	1,763	$62,208
2018	108	2,176	$87,264
2019	112	1,747	$66,493
2020	118	1,869	$94,754
2021	198	2,578	$114,569
2022	243	2,584	$130,752
2023	204	2,316	$139,069
2024	129	2,159	$109,959

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	62	426	$68,555
2016	63	412	$42,746
2017	72	500	$66,140
2018	66	352	$33,142
2019	82	488	$41,242
2020	93	589	$36,459
2021	76	320	$20,880
2022	71	182	$6,991
2023	86	251	$14,239
2024	149	663	$39,299

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	11	12	$103,216

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	117	395	$96
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	40	212	$50
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	41	77	$0
J1100	Injection, dexamethasone sodium phosphate, 1 mg	35	741	$0
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	34	53	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Buprenorphine	Buprenorphine	74	2,128	$19,428
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	88	2,353	$2,909
Buprenorphine Hcl	Buprenorphine Hcl	59	1,609	$2,580
Oxycodone Hcl	Oxycodone Hcl	130	3,285	$2,289
Fentanyl	Fentanyl	13	390	$2,282

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A6023	Collagen dressing, sterile, size more than 48 sq. in., each	N	11	12	$103,216

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	75	$5,981	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Geoffrey Louis Tyson, M.D.?

Tedicare shows public-source Medicare data for Geoffrey Louis Tyson, M.D. (NPI 1679610778), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Geoffrey Louis Tyson, M.D. have ACO affiliation data?

Geoffrey Louis Tyson, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Geoffrey Louis Tyson, M.D.?

Geoffrey Louis Tyson, M.D. is linked to SOUND PAIN ALLIANCE (billing NPI 1649776394) in the available physician profile data.

Does Geoffrey Louis Tyson, M.D. have Open Payments data?

Geoffrey Louis Tyson, M.D. has 75 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.